Spectral AI (NASDAQ:MDAI) is expected to release its earnings report for the third quarter of fiscal year 2025 after the market closes on November 11, 2025. Analysts anticipate the company will report earnings of ($0.08) per share and revenue of approximately $5.0620 million for the quarter. Investors are invited to visit the company’s earnings overview page for further details about the conference call scheduled for the same day at 5:00 PM ET.
In the previous earnings report, released on August 12, 2025, Spectral AI reported earnings of ($0.10) per share, falling short of the consensus estimate of ($0.07) by ($0.03). The company recorded revenue of $5.07 million, which was below the forecasted $5.44 million. Looking ahead, analysts project that Spectral AI will achieve an earnings per share (EPS) of $0 for the current fiscal year and ($1) for the next fiscal year.
Stock Performance and Institutional Interest
As of Friday, shares of Spectral AI opened at $1.94. The stock has a 50-day simple moving average of $2.17 and a 200-day moving average of $2.08. With a market capitalization of $53.58 million, the company currently has a price-to-earnings ratio of -2.81 and a beta of 0.91. Over the past year, the stock has fluctuated between a low of $1.01 and a high of $3.25.
Recent trading activity has seen several large investors adjust their positions in Spectral AI. Notably, Jane Street Group LLC acquired a new stake in the company worth approximately $74,000 during the second quarter. Marshall Wace LLP also purchased a new position valued at $104,000, while XTX Topco Ltd invested $123,000. Additionally, Geode Capital Management LLC increased its holdings by 21.8%, now owning 152,958 shares worth $379,000. Institutional investors and hedge funds currently hold 67.08% of the company’s stock.
Analysts’ Ratings and Market Outlook
Recent reports from various analysts indicate a cautious outlook for Spectral AI. Weiss Ratings maintained a “sell (e+)” rating on the stock as of October 31, 2025. Meanwhile, Wall Street Zen downgraded Spectral AI from a “hold” rating to a “strong sell” rating on August 16, 2025. Currently, one investment analyst has assigned a Buy rating, while another has given a Sell rating. According to data from MarketBeat, the consensus rating for Spectral AI is “Hold,” with an average price target of $3.50.
Spectral AI, headquartered in the United States, focuses on developing predictive medical diagnostics. The company aims to enhance treatment decisions in wound care, particularly for patients suffering from burns and diabetic foot ulcers. As the earnings announcement approaches, investors will keenly watch for any updates that may influence future performance.
